FDA approves ImmunityBio's bladder cancer treatment
The Food and Drug Administration on Monday approved Culver City-based ImmunityBio’s treatment for a type of bladder cancer.
Source: latimes.com
📰 Altor Bioscience News
Altor Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Altor Bioscience. Real-time updates on events, politics, business and more.
FDA approves bladder cancer treatment by Culver City company
The Food and Drug Administration on Monday approved Culver City-based ImmunityBio's treatment for a type of bladder cancer.
Source: yahoo.com
FDA Roundup: April 23, 2024
/PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA announced a new...
Source: prnewswire.com
Global Genomics Partnering Terms and Agreements Report 2016 to 2023: Disclosed Headlines, Upfronts, Milestones and Royalties by Stage of Development
/PRNewswire/ -- The "Global Genomics Partnering Terms and Agreements 2016 to 2023" report has been added to ResearchAndMarkets.coms offering. The Global...
Source: prnewswire.com
HCW Biologics Reports First Quarter 2023 Financial Results And Recent Business Highlights
MIRAMAR, Fla., May 09, 2023 -- HCW Biologics Inc. , a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the... | May 9, 2023
United States Rebecca Byam Altor Nantcell Masonic Cancer Center Nantcell Inc University Of Minnesota
Source: marketscreener.com
Global Cancer Gene Therapy Market to Reach $7.8 Billion by
The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s...
New York United States United Kingdom Altor Bioscience Oncolytic Virotherapy Oncogenex Pharmaceuticals Inc
Source: globenewswire.com
Metastatic Castration-Sensitive Prostate Cancer Market to Reach Upto USD 5.5 billion by 2032
/PRNewswire/ -- DelveInsights Metastatic Castration-Sensitive Prostate Cancer Market Insights report proffers a detailed comprehension of the Metastatic...
Source: prnewswire.com
DelveInsight Business Research, LLP: Metastatic Castration-Sensitive Prostate Cancer Market to Reach Upto USD 5.5 billion by 2032
Metastatic Castration-Sensitive Prostate Cancer market dynamics is anticipated to witness a significant growth owing to the rising prevalence of prostate cancer cases due to the rapidly aging
Source: finanznachrichten.de
Systemic Lupus Erythematosus Market to Advance Upto Whopping USD 10 Billion by 2030
/PRNewswire/ -- DelveInsights Systemic Lupus Erythematosus Market Insights report proffers a detailed comprehension of the Systemic Lupus Erythematosus market...
United States United Kingdom Takara Bio Altor Bioscience Johnson Janssen Gazyva Gazyvaro Obinutuzumab
Source: prnewswire.com
The Checkpoint Inhibitor Refractory Cancer Market is Expected to Witness Remarkable Growth During the Study Period (2018-30), Assesses DelveInsight
/PRNewswire/ -- DelveInsights Checkpoint Inhibitor Refractory Cancer Market Insights report covers a detailed comprehension of Checkpoint Inhibitor Refractory...
Source: prnewswire.com